CytoDyn Inc. Securities Fraud Class Action

The settlement of this federal securities fraud class action lawsuit is on behalf of investors who purchased or otherwise acquired CytoDyn, Inc. (“CytoDyn”) common stock between March 27, 2020 and March 30, 2022, inclusive (the “Class Period”).

CytoDyn agreed to provide 49 million shares of CytoDyn common stock and $500,000 in cash to resolve this class action lawsuit alleging the company and certain of its officers and/or directors violated federal securities laws by making false or misleading statements.

What’s the status of the Settlement?
On June 18, 2026, the Court granted Kessler Topaz Meltzer & Check’s Motion for Preliminary Approval of the Class Action Settlement, which was filed on behalf of the Lead Plaintiffs. There is a Final Settlement Hearing scheduled for November 2, 2026. The settlement website is active and open for claims.

Who can file a claim?
The settlement class includes all persons or entities who:

• Purchased or otherwise acquired CytoDyn common stock between March 27, 2020 and March 30, 2022, inclusive.

How much is the Settlement Payment?
Pro rata payment: The total settlement fund consists of 49 million shares of CytoDyn common stock and $500,000 in cash. The amount each class member receives will depend on several factors, including:

• • The number of valid claims submitted
  • The number of shares purchased and sold

• The dates of purchase and sale
• The price paid for the shares and the price received upon sale

How do I file a claim?
The deadline to file a claim is September 21, 2026. To submit a claim and/or to find additional information regarding the terms of the settlement and claim filing process, go to www.CytoDynSecuritiesSettlement.com, or contact the claims administrator, Strategic Claims Services, at 1-866-274-4004.

Read CytoDyn Inc. Securities Fraud Class Action FAQ Here

If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at [email protected]. 

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent.